Seven Eight Capital’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-8,150	Closed	-$365K	–	748
2024 Q2	$365K	Sell	8,150 -12,360	-60%	-$554K	0.04%	575
2024 Q1	$960K	Sell	20,510 -14,402	-41%	-$674K	0.1%	304
2023 Q4	$1.24M	Buy	+34,912	New	+$1.24M	0.14%	208